cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AF247787 | .c | 1 to 770 | 1 to 770 | exact | tiling clone, AAA | 770/770 (100 %) | 1 diff (99.9 %id) | ||
AK131052 | .e | 1 to 733 | 1 to 733 | exact | tiling clone, available from FLJ, | 733/733 (100 %) | 1 diff (99.9 %id) | ||
BC062416 | Uterus, leiomyosarcoma | .d | 178 to 998 | 1 to 821 | exact | tiling clone, available from MGC, AAA | 821/821 (100 %) | 0 diff (100 %id) | |
BF175482 | blood | .d | 261 to 504 | 1 to 240 | 240/241 (99 %) | 12 diff (95.1 %id) | |||
BQ695067 | adipose | .g | 1 to 338 | 1 to 338 | tiling clone, | 338/338 (100 %) | 2 diff (99.5 %id) | ||
BX283124 | lymph, lymphoma, cell line | .d | 188 to 690 | 1 to 503 | 503/503 (100 %) | 1 diff (99.9 %id) | |||
CD636375 | .d | 289 to 977 | 709 to 23 | 687/709 (96 %) | 5 diff (99.3 %id) | ||||
CD636376 | .d | 144 to 673 | 1 to 530 | 530/530 (100 %) | 4 diff (99.3 %id) | ||||
CN359794 | embryonic stem cells, DMSO-treated H9 cellline | .d | 1 to 516 | 1 to 516 | tiling clone, | 516/516 (100 %) | 3 diff (99.5 %id) | ||
CN359795 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 13 to 331 | 1 to 320 | 320/320 (100 %) | 3 diff (99.1 %id) | |||
BX501721 | Liver | .d | 175 to 779 | 1 to 605 | 605/605 (100 %) | 3 diff (99.6 %id) | |||
EC523963 | Prostate | .d | 319 to 404 | 91 to 7 | 85/91 (93 %) | 6 diff (93.5 %id) | |||
ES310691 | scalp interfollicular dermis, skin | .d | 149 to 590 | 1 to 442 | 442/442 (100 %) | 0 diff (100 %id) | |||
DA580845 | .d | 198 to 753 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |||
CN485251 | eye | .d | 209 to 832 | 1 to 624 | exact | 624/624 (100 %) | 0 diff (100 %id) | ||
H18776 | brain | .d | 354 to 724 | 1 to 374 | 374/405 (92 %) | 14 diff (96.6 %id) | |||
H18788 | brain | .d | 353 to 650 | 1 to 298 | 298/298 (100 %) | 9 diff (97.0 %id) | |||
N45044 | melanocyte | .d | 458 to 808 | 1 to 349 | 349/349 (100 %) | 7 diff (98.0 %id) | |||
W15293 | parathyroid gland, parathyroid tumor | .d | 723 to 994 | 283 to 12 | AAA | 272/426 (63 %) | 12 diff (97.2 %id) | ||
W39328 | parathyroid gland, parathyroid tumor | .d | 237 to 669 | 1 to 438 | 441/438 (100 %) | 22 diff (95.0 %id) | |||
W35318 | heart | .d | 242 to 646 | 16 to 417 | 401/419 (95 %) | 16 diff (96.2 %id) | |||
AA424087 | .d | 177 to 560 | 1 to 378 | 378/378 (100 %) | 8 diff (97.9 %id) | ||||
AA425695 | .g | 145 to 473 | 1 to 337 | tiling clone, | Submitted on the opposite strand | 337/337 (100 %) | 7 diff (98.0 %id) | ||
AA448643 | .d | 617 to 998 | 380 to 1 | 380/383 (99 %) | 8 diff (98.0 %id) | ||||
AA448739 | .d | 165 to 602 | 1 to 436 | 436/436 (100 %) | 11 diff (97.5 %id) | ||||
AA670415 | whole brain | .d | 527 to 994 | 471 to 7 | 465/480 (96 %) | 9 diff (98.2 %id) | |||
AA622314 | Prostate, prostate tumor | .d | 597 to 966 | 371 to 1 | 371/371 (100 %) | 33 diff (91.2 %id) | |||
AA844468 | parathyroid gland, parathyroid tumor | .d | 637 to 994 | 357 to 8 | 350/364 (96 %) | 1 diff (99.8 %id) | |||
AA897782 | pooled | .d | 623 to 731 | 109 to 1 | 109/109 (100 %) | 10 diff (90.9 %id) | |||
AA953870 | pooled | .d | 631 to 994 | 363 to 1 | 363/363 (100 %) | 13 diff (96.5 %id) | |||
AI017161 | pooled | .d | 446 to 994 | 557 to 10 | 548/557 (98 %) | 7 diff (98.8 %id) | |||
AI051130 | brain, glioblastoma (pooled) | .d | 542 to 994 | 454 to 2 | 453/454 (99 %) | 0 diff (100 %id) | |||
AI125860 | .e | 145 to 733 | 591 to 4 | 588/591 (99 %) | 18 diff (97.0 %id) | ||||
AI218850 | pooled | .d | 410 to 994 | 591 to 7 | 585/600 (97 %) | 11 diff (98.2 %id) | |||
AI220316 | pooled | .d | 561 to 994 | 437 to 4 | 434/438 (99 %) | 15 diff (96.6 %id) | |||
AI205498 | pooled germ cell tumors | .d | 771 to 994 | 232 to 9 | 224/233 (96 %) | 0 diff (100 %id) | |||
AI655302 | pooled germ cell tumors | .d | 497 to 994 | 506 to 9 | 498/506 (98 %) | 4 diff (99.3 %id) | |||
AI810885 | Prostate | .d | 434 to 994 | 561 to 1 | 561/561 (100 %) | 13 diff (97.7 %id) | |||
AI653066 | pooled germ cell tumors | .d | 469 to 994 | 534 to 9 | 526/537 (97 %) | 13 diff (97.6 %id) | |||
AI653084 | pooled germ cell tumors | .d | 461 to 994 | 542 to 9 | 534/542 (98 %) | 3 diff (99.5 %id) | |||
AI673127 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .d | 721 to 994 | 279 to 6 | 274/279 (98 %) | 0 diff (100 %id) | |||
AI828024 | pooled | .e | 212 to 733 | 525 to 4 | tiling clone, | 522/525 (99 %) | 0 diff (100 %id) | ||
AI767676 | Kidney | .d | 517 to 994 | 486 to 8 | 479/486 (98 %) | 2 diff (99.6 %id) | |||
AI760957 | 2 pooled tumors (clear cell type), Kidney | .d | 748 to 994 | 252 to 6 | 247/252 (98 %) | 0 diff (100 %id) | |||
AI885860 | anaplastic oligodendroglioma, brain | .d | 527 to 994 | 473 to 6 | 468/482 (97 %) | 9 diff (98.2 %id) | |||
AW444593 | .d | 646 to 994 | 366 to 18 | AAA | 349/349 (100 %) | 3 diff (99.2 %id) | |||
BM986840 | mixed | .d | 607 to 994 | 406 to 19 | AAA | 388/388 (100 %) | 11 diff (97.2 %id) | ||
BE261354 | brain, neuroblastoma | .d | 194 to 742 | 1 to 549 | 549/549 (100 %) | 1 diff (99.9 %id) | |||
BE858111 | brain, glioblastoma (pooled) | .d | 413 to 994 | 582 to 1 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
BE279986 | choriocarcinoma, placenta | .d | 170 to 852 | 1 to 676 | A76C L77S Q78A L80A L82P ... | 676/722 (93 %) | 24 diff (96.7 %id) | ||
BF033739 | adenocarcinoma, ovary | .d | 166 to 811 | 1 to 649 | 649/1105 (58 %) | 13 diff (98.9 %id) | |||
BE906132 | epithelioid carcinoma, Pancreas | .d | 189 to 937 | 1 to 745 | E177G V178G E179G E180G K181E ... | 745/933 (79 %) | 18 diff (98.1 %id) | ||
BE910288 | epithelioid carcinoma, Pancreas | .d | 522 to 934 | 13 to 424 | Suspected internal deletion | 604/948 (63 %) | 8 diff (99.2 %id) | ||
BE885232 | leiomyosarcoma, uterus | .d | 239 to 795 | 46 to 614 | 573/816 (70 %) | 26 diff (96.9 %id) | |||
BE903777 | choriocarcinoma, placenta | .d | 149 to 732 | 1 to 590 | 590/870 (67 %) | 17 diff (98.1 %id) | |||
BF182711 | large cell carcinoma, lung | .d | 155 to 911 | 1 to 754 | exact | 754/1017 (74 %) | 22 diff (97.9 %id) | ||
BG324988 | Kidney, renal cell adenocarcinoma | .d | 143 to 869 | 1 to 630 | S10R P12T T13R V14S Y15R ... | 515/630 (81 %) | 39 diff (93.9 %id) | ||
BG385764 | adenocarcinoma cell line, colon | .d | 279 to 970 | 1 to 686 | 686/835 (82 %) | 25 diff (97.1 %id) | |||
BG774911 | carcinoma, cell line, Prostate | .d | 193 to 931 | 1 to 740 | E179D E180G K181E S183Q W184L ... | fully sequenced, | 740/740 (100 %) | 3 diff (99.6 %id) | |
BG775374 | carcinoma, cell line, Prostate | .d | 372 to 950 | 577 to 2 | fully sequenced, | 576/577 (99 %) | 0 diff (100 %id) | ||
BM010343 | amelanotic melanoma, cell line, skin | .d | 22 to 789 | 1 to 766 | 766/793 (96 %) | 9 diff (98.9 %id) | |||
BM474974 | duodenal adenocarcinoma, cell line, small intestine | .e | 60 to 733 | 1 to 678 | tiling clone, AAA | 678/678 (100 %) | 4 diff (99.5 %id) | ||
BM808338 | ovary (pool of 3) | .h-u | 70 to 928 | 11 to 879 | tiling clone, | 869/1082 (80 %) | 6 diff (99.5 %id) | ||
BM021050 | Islets of Langerhans, Pancreas | .d | 657 to 994 | 350 to 14 | fully sequenced, AAA | 337/337 (100 %) | 4 diff (98.9 %id) | ||
BM021274 | Islets of Langerhans, Pancreas | .d | 146 to 687 | 11 to 552 | fully sequenced, | 542/552 (98 %) | 6 diff (99.0 %id) | ||
BQ267991 | insulinoma, Pancreas | .d | 693 to 998 | 321 to 15 | fully sequenced, AAA | 307/307 (100 %) | 5 diff (98.4 %id) | ||
BQ268256 | insulinoma, Pancreas | .d | 409 to 754 | 8 to 353 | fully sequenced, | 346/353 (98 %) | 6 diff (98.4 %id) | ||
BQ057610 | lymph, lymphoma, cell line | .d | 190 to 957 | 1 to 779 | V170G L171A L172A V173G V174T ... | 779/1079 (72 %) | 20 diff (98.2 %id) | ||
BQ061012 | lymph, lymphoma, cell line | .d | 191 to 925 | 1 to 737 | exact | 737/1072 (68 %) | 5 diff (99.6 %id) | ||
BQ062311 | lymph, lymphoma, cell line | .d | 190 to 925 | 1 to 737 | exact | 737/1049 (70 %) | 7 diff (99.4 %id) | ||
BU192150 | large cell carcinoma, lung | .d | 499 to 994 | 1 to 498 | 498/558 (89 %) | 4 diff (99.3 %id) | |||
BU196042 | melanotic melanoma, cell line, skin | .d | 376 to 912 | 1 to 537 | 537/958 (56 %) | 8 diff (99.2 %id) | |||
BC051380 | Pancreas, adenocarcinoma | .a | 44 to 845 | 1 to 802 | tiling clone, available from MGC, AAA | 802/802 (100 %) | 1 diff (99.9 %id) | ||
BU179608 | adenocarcinoma, Pancreas | .a | 45 to 676 | 1 to 635 | available from MGC, | 635/990 (64 %) | 19 diff (98.1 %id) | ||
BU179627 | adenocarcinoma, Pancreas | .a | 45 to 757 | 1 to 718 | 718/964 (74 %) | 11 diff (98.9 %id) | |||
BQ900961 | sympathetic trunk | .a | 1 to 553 | 1 to 553 | tiling clone, | 553/877 (63 %) | 17 diff (98.1 %id) | ||
BQ924400 | large cell carcinoma, lung | .a | 39 to 841 | 1 to 803 | 803/824 (97 %) | 13 diff (98.5 %id) | |||
BU509078 | leiomyosarcoma, uterus | .d | 179 to 925 | 1 to 753 | E179A E180G K181E S183Q W184L ... | 753/910 (82 %) | 26 diff (97.2 %id) | ||
TI_59385155 | .d | 23 to 789 | 105 to 869 | 765/792 (96 %) | 8 diff (99.0 %id) | ||||
CB157309 | Liver | .f | 1 to 556 | 3 to 558 | exact | tiling clone, | 558/558 (100 %) | 0 diff (100 %id) | |
BP306550 | .e | 1 to 583 | 1 to 583 | H56Q E57R R58T Q59A R60A ... | 583/584 (99 %) | 4 diff (99.4 %id) | |||
NM_138334.2 | .c | 1 to 770 | 1 to 770 | exact | RefSeq, AAA | 770/770 (100 %) | 1 diff (99.9 %id) | ||
BP328576 | rectum | .b | 1 to 581 | 2 to 582 | tiling clone, | 582/582 (100 %) | 0 diff (100 %id) | ||
CT000665 | T-Lymphocytes | .e | 14 to 537 | 1 to 524 | 524/527 (99 %) | 1 diff (99.9 %id) | |||
BM790832 | stomach | .e | 1 to 516 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM792044 | Ascites, stomach | .j | 1 to 583 | 1 to 583 | exact | tiling clone, | 583/583 (100 %) | 0 diff (100 %id) | |
BQ083148 | Ascites, stomach | .d | 418 to 748 | 1 to 331 | 331/331 (100 %) | 0 diff (100 %id) | |||
DB030025 | testis | .h-u | 1 to 584 | 2 to 588 | A25X V26R A27G G28L V29G ... | tiling clone, capped | 587/587 (100 %) | 3 diff (99.5 %id) | |
TI_149287826 | .d | 242 to 999 | 839 to 82 | L33V L80V L121M | AAA | 758/1012 (74 %) | 4 diff (99.7 %id) | ||
TI_149302242 | .b | 37 to 840 | 880 to 77 | tiling clone, AAA | 804/975 (82 %) | 6 diff (99.4 %id) | |||
TI_159715020 | .i | 1 to 637 | 739 to 103 | exact | AAA | 637/1028 (61 %) | 1 diff (100.0 %id) | ||
BM970016 | lung | .d | 260 to 999 | 758 to 19 | tiling clone, AAA | 740/740 (100 %) | 3 diff (99.6 %id) | ||
BM980474 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 242 to 998 | 776 to 19 | V14R Y15V H16P E17R R18T ... | AAA | 758/759 (99 %) | 2 diff (99.8 %id) | |
CB851833 | Human Lung Epithelial cells, lung | .i | 1 to 637 | 655 to 19 | exact | tiling clone, AAA | 637/652 (97 %) | 1 diff (99.9 %id) | |
BM694260 | eye, RPE and Choroid | .d | 186 to 655 | 1 to 470 | 470/470 (100 %) | 0 diff (100 %id) | |||
BQ575464 | Chondrosarcoma Grade II, Left Pelvis | .d | 330 to 994 | 682 to 19 | AAA | 664/666 (99 %) | 2 diff (99.7 %id) | ||
BQ575045 | Chondrosarcoma Grade II, Left Pelvis | .d | 275 to 998 | 742 to 19 | AAA | 724/724 (100 %) | 0 diff (100 %id) | ||
BQ576058 | Chondrosarcoma Grade II, Left Pelvis | .d | 283 to 998 | 733 to 19 | AAA | 715/715 (100 %) | 3 diff (99.6 %id) | ||
CA418805 | Chondrosarcoma Grade II, Left Pelvis | .d | 505 to 994 | 508 to 19 | AAA | 490/490 (100 %) | 0 diff (100 %id) | ||
CA425740 | cell lines, Chondrosarcoma | .d | 519 to 994 | 494 to 19 | AAA | 476/476 (100 %) | 1 diff (99.8 %id) | ||
BU623847 | cell lines, Enchondroma | .d | 194 to 994 | 815 to 19 | Y15T H16T E17N R18G Q19S ... | AAA | 800/802 (99 %) | 10 diff (98.8 %id) | |
BU624373 | cell lines, Enchondroma | .d | 401 to 994 | 612 to 19 | AAA | 594/615 (96 %) | 0 diff (100 %id) | ||
CA308981 | Alveolar Macrophage, lung | .d | 804 to 994 | 207 to 16 | AAA | 192/200 (96 %) | 3 diff (98.5 %id) | ||
BU192150 | large cell carcinoma, lung | .d | 499 to 994 | 1 to 498 | 498/558 (89 %) | 4 diff (99.3 %id) | |||
BU196042 | melanotic melanoma, cell line, skin | .d | 376 to 912 | 1 to 537 | 537/958 (56 %) | 8 diff (99.2 %id) | |||
BU196042 | IMAGE:6074446 | JOSD2.dAug10 | 912 | 537 | IMAGE:6074446 | 537 | 8 | ||
BC051380 | IMAGE:6107198 | JOSD2.aAug10 | 845 | 802 | IMAGE:6107198 | 802 | 1 | ||
BU179608 | IMAGE:6107198__1 | JOSD2.aAug10 | 676 | 635 | IMAGE:6107198__1 | 635 | 19 | ||
BU179608 | IMAGE:6107198__1 | JOSD2.aAug10 | 676 | 635 | IMAGE:6107198__1 | 635 | 19 | ||
BU179627 | IMAGE:6107279 | JOSD2.aAug10 | 757 | 718 | IMAGE:6107279 | 718 | 11 | ||
BU179627 | IMAGE:6107279 | JOSD2.aAug10 | 757 | 718 | IMAGE:6107279 | 718 | 11 | ||
BQ900961 | IMAGE:6192318 | JOSD2.aAug10 | 553 | 553 | IMAGE:6192318 | 553 | 17 | ||
BQ924400 | IMAGE:6459116 | JOSD2.aAug10 | 841 | 803 | IMAGE:6459116 | 803 | 13 | ||
BQ924400 | IMAGE:6459116 | JOSD2.aAug10 | 841 | 803 | IMAGE:6459116 | 803 | 13 | ||
BU509078 | IMAGE:6503623 | JOSD2.dAug10 | 925 | 753 | IMAGE:6503623 | 753 | 26 | ||
BU509078 | IMAGE:6503623 | JOSD2.dAug10 | 925 | 753 | IMAGE:6503623 | 753 | 26 | ||
TI_59385155 | INCYTE_603631243 | JOSD2.dAug10 | 789 | 869 | INCYTE_603631243 | 765 | 8 | ||
CB157309 | L12JSHC0s1-7-H11 | JOSD2.fAug10 | 556 | 558 | L12JSHC0s1-7-H11 | 558 | 0 | ||
BP306550 | MPG07859 | JOSD2.eAug10 | 583 | 583 | MPG07859 | 583 | 4 | ||
NM_138334.2 | NM_138334 | JOSD2.cAug10 | 770 | 770 | NM_138334 | 770 | 1 | ||
BP328576 | RCT01142 | JOSD2.bAug10 | 581 | 582 | RCT01142 | 582 | 0 | ||
CT000665 | RZPDp9016E1626 | JOSD2.eAug10 | 537 | 524 | RZPDp9016E1626 | 524 | 1 | ||
BM790832 | S21SNU520-16-E03 | JOSD2.eAug10 | 516 | 516 | S21SNU520-16-E03 | 516 | 0 | ||
BM792044 | S22SNU16n1-10-G06 | JOSD2.jAug10 | 583 | 583 | S22SNU16n1-10-G06 | 583 | 0 | ||
BM792044 | S22SNU16n1-10-G06 | JOSD2.jAug10 | 583 | 583 | S22SNU16n1-10-G06 | 583 | 0 | ||
BQ083148 | S22SNU16n1-138-H02 | JOSD2.dAug10 | 748 | 331 | S22SNU16n1-138-H02 | 331 | 0 | ||
BQ083148 | S22SNU16n1-138-H02 | JOSD2.dAug10 | 748 | 331 | S22SNU16n1-138-H02 | 331 | 0 | ||
DB030025 | TESTI2013441 | JOSD2.hAug10-unspliced | 584 | 588 | TESTI2013441 | 587 | 3 | ||
TI_149287826 | TI_149287826 | JOSD2.dAug10 | 999 | 82 | TI_149287826 | 758 | 4 | ||
TI_149302242 | TI_149302242 | JOSD2.bAug10 | 840 | 77 | TI_149302242 | 804 | 6 | ||
TI_159715020 | TI_159715020 | JOSD2.iAug10 | 637 | 103 | TI_159715020 | 637 | 1 | ||
BM970016 | UI-CF-EC1-abu-g-12-0-UI | JOSD2.dAug10 | 999 | 19 | UI-CF-EC1-abu-g-12-0-UI | 740 | 3 | ||
BM980474 | UI-CF-EN1-add-k-01-0-UI | JOSD2.dAug10 | 998 | 19 | UI-CF-EN1-add-k-01-0-UI | 758 | 2 | ||
BM980474 | UI-CF-EN1-add-k-01-0-UI | JOSD2.dAug10 | 998 | 19 | UI-CF-EN1-add-k-01-0-UI | 758 | 2 | ||
CB851833 | UI-CF-FN0-aem-o-19-0-UI | JOSD2.iAug10 | 637 | 19 | UI-CF-FN0-aem-o-19-0-UI | 637 | 1 | ||
CB851833 | UI-CF-FN0-aem-o-19-0-UI | JOSD2.iAug10 | 637 | 19 | UI-CF-FN0-aem-o-19-0-UI | 637 | 1 | ||
BM694260 | UI-E-CI1-afo-p-14-0-UI | JOSD2.dAug10 | 655 | 470 | UI-E-CI1-afo-p-14-0-UI | 470 | 0 | ||
BM694260 | UI-E-CI1-afo-p-14-0-UI | JOSD2.dAug10 | 655 | 470 | UI-E-CI1-afo-p-14-0-UI | 470 | 0 | ||
BQ575464 | UI-H-EZ1-bbb-j-04-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-EZ1-bbb-j-04-0-UI | 664 | 2 | ||
BQ575464 | UI-H-EZ1-bbb-j-04-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-EZ1-bbb-j-04-0-UI | 664 | 2 | ||
BQ575045 | UI-H-EZ1-bbd-o-17-0-UI | JOSD2.dAug10 | 998 | 19 | UI-H-EZ1-bbd-o-17-0-UI | 724 | 0 | ||
BQ575045 | UI-H-EZ1-bbd-o-17-0-UI | JOSD2.dAug10 | 998 | 19 | UI-H-EZ1-bbd-o-17-0-UI | 724 | 0 | ||
BQ576058 | UI-H-EZ1-bbg-g-21-0-UI | JOSD2.dAug10 | 998 | 19 | UI-H-EZ1-bbg-g-21-0-UI | 715 | 3 | ||
BQ576058 | UI-H-EZ1-bbg-g-21-0-UI | JOSD2.dAug10 | 998 | 19 | UI-H-EZ1-bbg-g-21-0-UI | 715 | 3 | ||
CA418805 | UI-H-EZ1-bbg-i-02-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-EZ1-bbg-i-02-0-UI | 490 | 0 | ||
CA418805 | UI-H-EZ1-bbg-i-02-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-EZ1-bbg-i-02-0-UI | 490 | 0 | ||
CA425740 | UI-H-FE1-bef-o-15-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FE1-bef-o-15-0-UI | 476 | 1 | ||
CA425740 | UI-H-FE1-bef-o-15-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FE1-bef-o-15-0-UI | 476 | 1 | ||
BU623847 | UI-H-FG1-bgh-a-18-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FG1-bgh-a-18-0-UI | 800 | 10 | ||
BU623847 | UI-H-FG1-bgh-a-18-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FG1-bgh-a-18-0-UI | 800 | 10 | ||
BU624373 | UI-H-FG1-bgj-p-14-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FG1-bgj-p-14-0-UI | 594 | 0 | ||
BU624373 | UI-H-FG1-bgj-p-14-0-UI | JOSD2.dAug10 | 994 | 19 | UI-H-FG1-bgj-p-14-0-UI | 594 | 0 | ||
CA308981 | UI-H-FT1-bhz-i-19-0-UI | JOSD2.dAug10 | 994 | 16 | UI-H-FT1-bhz-i-19-0-UI | 192 | 3 | ||
CA308981 | UI-H-FT1-bhz-i-19-0-UI | JOSD2.dAug10 | 994 | 16 | UI-H-FT1-bhz-i-19-0-UI | 192 | 3 |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |